Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eidon Salus is an Italian pharmaceutical and nutraceutical company dedicated to the development of innovative health solutions, particularly in the fields of ophthalmology and neurology. The company focuses on neuroprotection and metabolic health, offering a portfolio of specialized products designed to support patients with chronic conditions such as glaucoma, diabetic retinopathy, and peripheral neuropathy. Eidon Salus leverages scientific research to formulate high-quality supplements and medical devices, including its flagship brands Eidonerv and Eidonorm. Headquartered in Rome, the company operates primarily within the Italian market while seeking to expand its scientific footprint in the life sciences sector. Their approach combines clinical evidence with advanced formulations to address unmet needs in ocular and neural wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eidon Salus.